tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CALC Stock Latest News

CalciMedica price target raised to $20 from $14 at Oppenheimer
The FlyCalciMedica price target raised to $20 from $14 at Oppenheimer
12d ago
CALC
CalciMedica enrolls first patient in trial of Auxora in acute kidney injury
PremiumThe Fly
CalciMedica enrolls first patient in trial of Auxora in acute kidney injury
13d ago
CALC
CalciMedica set to join Russell Microcap Index
PremiumThe Fly
CalciMedica set to join Russell Microcap Index
21d ago
CALC
CalciMedica price target lowered to $15 from $22 at JonesResearch
PremiumThe Fly
CalciMedica price target lowered to $15 from $22 at JonesResearch
25d ago
CALC
CalciMedica’s Auxora Shows Promise in Acute Pancreatitis Trial
PremiumCompany Announcements
CalciMedica’s Auxora Shows Promise in Acute Pancreatitis Trial
25d ago
8K
CALC
CalciMedica’s Auxora shows efficacy in Acute Pancreatitis Phase 2b trial
PremiumThe FlyCalciMedica’s Auxora shows efficacy in Acute Pancreatitis Phase 2b trial
25d ago
CALC
CalciMedica jumps 21% after announcing conference call review Auxora trial
PremiumThe Fly
CalciMedica jumps 21% after announcing conference call review Auxora trial
25d ago
CALC
CalciMedica Reports First Quarter 2024 Financial Results and Provides Clinical & Corporate Updates
PremiumPress Releases
CalciMedica Reports First Quarter 2024 Financial Results and Provides Clinical & Corporate Updates
2M ago
CALC
CalciMedica reports Q1 EPS 1c with items, consensus (67c)
PremiumThe Fly
CalciMedica reports Q1 EPS 1c with items, consensus (67c)
2M ago
CALC
CALC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
CALC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
CALC
CalciMedica enrolls last patient in Phase 2b CARPO trial of Auxora
PremiumThe Fly
CalciMedica enrolls last patient in Phase 2b CARPO trial of Auxora
3M ago
CALC
CalciMedica Reports 2023 Financial Results and Provides Clinical & Corporate Updates
PremiumPress Releases
CalciMedica Reports 2023 Financial Results and Provides Clinical & Corporate Updates
4M ago
CALC
CalciMedica presented preclinical data from studies of Auxora in acute AKI
PremiumThe FlyCalciMedica presented preclinical data from studies of Auxora in acute AKI
4M ago
CALC
CalciMedica initiated with a Buy at JonesResearch
PremiumThe Fly
CalciMedica initiated with a Buy at JonesResearch
5M ago
CALC
CalciMedica Advances Auxora in Kidney Injury Trial
PremiumCompany Announcements
CalciMedica Advances Auxora in Kidney Injury Trial
5M ago
8K
CALC
CalciMedica: FDA clears IND application for Phase 2 trial of Auxora
PremiumThe Fly
CalciMedica: FDA clears IND application for Phase 2 trial of Auxora
5M ago
CALC
Calcimedica Inc trading resumes
PremiumThe Fly
Calcimedica Inc trading resumes
6M ago
CALC
Calcimedica Inc trading halted, volatility trading pause
PremiumThe Fly
Calcimedica Inc trading halted, volatility trading pause
6M ago
CALC
CalciMedica files to sell 10.74M shares of common stock for holders
PremiumThe Fly
CalciMedica files to sell 10.74M shares of common stock for holders
6M ago
CALC
Palo Alto downgraded, Dollar Tree upgraded: Wall Street’s top analyst calls
PremiumThe FlyPalo Alto downgraded, Dollar Tree upgraded: Wall Street’s top analyst calls
6M ago
ZI
AAL
CalciMedica initiated with a Buy at H.C. Wainwright
PremiumThe Fly
CalciMedica initiated with a Buy at H.C. Wainwright
6M ago
CALC
CalciMedica announces $55M private placement
PremiumThe Fly
CalciMedica announces $55M private placement
6M ago
CALC

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >